Ascendis Announces Oral Presentation of Week 104 Data from Its Pivotal Trial of TransCon® CNP (Navepegritide) at ISDS 2026
Go back to Ascendis Announces Oral Presentation of Week 104 Data from Its Pivotal Trial of TransCon® CNP (Navepegritide) at ISDS 2026| Asianada, Inc. (NASDAQ: ASND) | Delayed: 270.56 -0.56 (0.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $271.12 | 52 Week High | $21.79 | |||
| Open | $267.96 | 52 Week Low | $11.92 | |||
| Day High | $271.14 | P/E | N/A | |||
| Day Low | $265.22 | EPS | $-0.07 | |||
| Volume | 723,516 | |||||

